Single Nucleotide Polymorphism at +276 G>T of the Adiponectin Gene and Plasma Adiponectin Level in Myanmar Type 2 Diabetic Patients

Khin Yu, Kyu Kyu Maung, Aye Thida, Thein Myint


Objective: The aim of the study was to investigate the association between single nucleotide polymorphism (SNP) at rs 1501299 (SNP+276 G>T) of adiponectin gene and plasma adiponectin level in Myanmar type 2 diabetic (T2DM) patients.

Methodology: It was a cross-sectional analytical study.100 T2DM patients and 104 non-diabetic subjects were included. Genotype frequencies were determined by PCR-RFLP method and plasma adiponectin level was measured by ELISA method.

Result: Genotype frequencies (GG, GT, TT) of SNP+276 in diabetic patients were 39%, 48% and 13% respectively. GT and TT genotype subjects were more likely to develop T2DM risk than GG subjects [OR =1.98 (95% CI =1.10-3.55, p = 0.02) and OR = 4.07 (95% CI =1.34-12.3, p = 0.01)] respectively. T alleles of SNP+276 was found to statistically increase T2DM risk than G allele [OR=1.96(95%CI=1.27-3.01, p=0.002)]. Mean plasma adiponectin level (27.41±16.7µg/ml) of T2DM patients was significantly lower than that of non-diabetic subjects (37.19±26.77 µg/ml), (p =0.002).

Conclusion: It can be concluded that SNP +276 at rs 1501299 of adiponectin gene had high risk of type 2 diabetes with low plasma adiponectin level in Myanmar populations.


adiponectin gene, SNP, type 2 diabetes

Full Text:

Abstract HTML PDF


Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51(2):536-40. PMID: 11812766.

Kaput J, Noble J, Hatipoglu B, Kohrs K, Dawson K, Bartholomew A. Application of nutrigenomic concepts to type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2007;17(2):89-103. PMID: 17276047.

Li LL, Kang XL, Ran XJ, et al. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin Exp Pharmacol Physiol. 2007;34(12):1287-90.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-92. PMID: 16823476. PMCID: PMC1483172.

Mohammadzadeh G, Zarghami N. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. Scand J Clin Lab Invest. 2009;69(7):764–71. PMID: 19929719.

Melistas L, Mantzoros CS, Kontogianni M, Antonopoulou S, Ordovas JM, Yiannakouris N. Association of the +45 T>G and +276 G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol. 2009;161(6):845-52. PMID: 19755407. PMCID: PMC2896503.

Yang WS, Yang YC, Chen CL, et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr. 2007;86(2):509-13. PMID: 17684226.

Jalovaara K, Santaniemi M, Timonen M, et al. Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism. 2008;57(8):1130-4. PMID: 18640392.

Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care 2003;26(12):3226-9. PMID: 14633806.

Aleidi S, Issa A, Bustanji H, Khalil M, Bustanji Y. Adiponectin serum levels correlate with resistance in type 2 diabetic patients. Saudi Pharm J. 2015;23(3):250-6. PMID: 26106273. PMCID: PMC4475813.

World Health Organization and International Diabetes Federation.

Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. Geneva: WHO, 2006.

Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881-5. PMID: 17293876.

Mackawy AMH, Alzohairy MAA, Ahmed EAA, Badawy MEH. Adiponectin gene polymorphism and the incidence of type 2 diabetes mellitus in obese patients in Qassim region, Saudi Arabia. J Am Sci. 2011;7(12):432-43.

Thirunavukkarasu A, Nithya R, Muthukumaran K, Sivasankari C. Association of the 45 T/G and 276 G/T polymorphisms in the adiponectin

gene with type 2 diabetes in South Indian population. J Environ Res Develop. 2014;8(3A):563-7.

Siitonen N, Pulkkinen L, Lindstrom J, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: The Finnish Diabetes Prevention Study. BMC Med Genet. 2011;12:5. PMID: 21219602. PMCID: PMC3032655.

Hotta K, Funahashi TA, Arita Y et al. Plasma concentrations of a novel,

adipose specific protein, adiponectin in type 2 Diabetic patients. Arterioscler

Thromb Vasc Biol. 2000;20(6):1595-9. PMID: 10845877.

Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care. 2003;26(12):3226-9. PMID: 14633806.

Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA. 2009;302(2):179-88. PMID: 19584347.

Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002; Vol-51(7):2306-12. PMID: 12086965.

Huang MC, Wang TN, Lee KT. Adiponectin gene SNP276 variants and central obesity confer risks for hyperglycemia in indigenous Taiwanese. Kaohsiung J Med Sci. 2010:26(5):227-36. PMID: 20466332.